Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath Test
NCT05045495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 211
Last updated 2022-05-24
Summary
An adult pilot study to establish the normal reference range and optimal cutoffs for the oral 50g Sucrose Challenge Test (SCT) and the 50g 13C-Sucrose Breath Test (CBT) for patients with CSID and healthy controls. This study will enroll 120 healthy controls and 50 CSID patients. No study drug will be administered during this study.
Conditions
- Congenital Sucrase-Isomaltase Deficiency
Interventions
- DIAGNOSTIC_TEST
-
Sucrose Hydrogen Methane Breath Test
Subjects will collect 2 buccal swabs for the sucrase genetic test and then subjects will simultaneously conduct the sucrose challenge test, sucrose hydrogen methane breath test, and the 13C-sucrose following ingestion of 50-grams of sucrose (table sugar) mixed with 8 ounce of water.
Sponsors & Collaborators
-
QOL Medical, LLC
lead INDUSTRY
Principal Investigators
-
Weng Tao, M.D., Ph. D · QOL Medical
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-30
- Primary Completion
- 2022-02-28
- Completion
- 2022-02-28
Countries
- United States
Study Locations
More Related Trials
-
Healthy Volunteer Short Chain Fatty Acid Study
NCT05254340 ·Status: TERMINATED ·Phase: NA
-
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
NCT05601635 ·Status: COMPLETED ·Phase: NA
-
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression
NCT05291104 ·Status: COMPLETED ·Phase: NA
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of EUS Guided Celiac Block
NCT00583271 ·Status: COMPLETED
-
Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
NCT00999232 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
NCT01438411 ·Status: COMPLETED ·Phase: PHASE3
-
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders
NCT01195753 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004368 ·Status: UNKNOWN ·Phase: PHASE1
-
Quantitative Liver Function Tests Using Cholates
NCT01907074 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Trial of Silymarin for Chronic Liver Diseases
NCT00389376 ·Status: COMPLETED ·Phase: PHASE1
-
Liver Metabolic Functions in Patients With Citrin Deficiency and Healthy Subjects
NCT07055269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency
NCT02784067 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
NCT00364689 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of CNT-01 in Patients With Idiopathic TGCV
NCT02502578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study to Explore the Role of Gut Flora in Fatty Liver
NCT04160949 ·Status: WITHDRAWN
-
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders
NCT00718627 ·Status: COMPLETED ·Phase: PHASE2
-
Glycosade v UCCS in the Dietary Management of Hepatic GSD
NCT02318966 ·Status: COMPLETED ·Phase: NA
-
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
NCT02925520 ·Status: NO_LONGER_AVAILABLE
-
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
NCT03632993 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)
NCT02598128 ·Status: COMPLETED ·Phase: NA